TY - JOUR
T1 - A gene-expression signature can quantify the degree of hepatic fibrosis in the rat
AU - Utsunomiya, Tohru
AU - Okamoto, Masahiro
AU - Hashimoto, Masaji
AU - Yoshinaga, Keiji
AU - Shiraishi, Takeshi
AU - Tanaka, Fumiaki
AU - Mimori, Koshi
AU - Inoue, Hiroshi
AU - Watanabe, Goro
AU - Barnard, Graham F.
AU - Mori, Masaki
N1 - Funding Information:
This work was supported in part by a Health and Labour Sciences Research Grant on Hepatitis (H13-Hepatitis-6), the Ministry of Health, Labour and Welfare of Japan. Also by Grants-in-Aid for Scientific Research (B) (15390398 and 14370358) and for Scientific Research (C) (15591412 and 15591411), Japan Society for the Promotion of Science and Grants-in-Aid for Exploratory Research (14657286), the Ministry of Education, Culture, Sports, Science and Technology of Japan.
PY - 2004/9
Y1 - 2004/9
N2 - A more accurate and objective quantification of hepatic fibrosis would provide clinically useful information for the monitoring of chronic liver disease progression and therapy recommendation.Using a cDNA microarray of 14,814 clones, we analyzed the gene-expression profiles of fibrotic livers in a rat model.We identified 750 up- and 345 down-regulated genes by combining a signal-to-noise score and a random permutation test (P<0.01). The functions of these genes provided insight into the underlying molecular mechanisms of both structural remodeling and functional deficits in cirrhosis. To quantify the extent of liver fibrosis, we have generated for the first time a 'genetic fibrosis index' based on gene-expression profiling of 95 genes by combining a Pearson correlation coefficient and a 'leave-one-out' cross-validation procedure. This technique based on a supervised learning analysis correctly quantified the various degrees of fibrosis in both 20 training samples (R 2=0.829, P<0.001) and 6 test samples (R 2=0.822, P<0.05).Our method will assist researchers in identifying rational targets for intervention and might help clinicians to objectively monitor the severity of liver fibrosis.
AB - A more accurate and objective quantification of hepatic fibrosis would provide clinically useful information for the monitoring of chronic liver disease progression and therapy recommendation.Using a cDNA microarray of 14,814 clones, we analyzed the gene-expression profiles of fibrotic livers in a rat model.We identified 750 up- and 345 down-regulated genes by combining a signal-to-noise score and a random permutation test (P<0.01). The functions of these genes provided insight into the underlying molecular mechanisms of both structural remodeling and functional deficits in cirrhosis. To quantify the extent of liver fibrosis, we have generated for the first time a 'genetic fibrosis index' based on gene-expression profiling of 95 genes by combining a Pearson correlation coefficient and a 'leave-one-out' cross-validation procedure. This technique based on a supervised learning analysis correctly quantified the various degrees of fibrosis in both 20 training samples (R 2=0.829, P<0.001) and 6 test samples (R 2=0.822, P<0.05).Our method will assist researchers in identifying rational targets for intervention and might help clinicians to objectively monitor the severity of liver fibrosis.
UR - http://www.scopus.com/inward/record.url?scp=4344576756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4344576756&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2004.05.015
DO - 10.1016/j.jhep.2004.05.015
M3 - Article
C2 - 15336442
AN - SCOPUS:4344576756
SN - 0168-8278
VL - 41
SP - 399
EP - 406
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 3
ER -